Long Focus Capital Management LLC 13D and 13G filings for Vincerx Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-11 7:09 pm Sale |
2024-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Long Focus Capital Management LLC | 0 0.000% |
-54,938![]() (Position Closed) |
Filing |
2024-02-14 5:10 pm Sale |
2023-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Long Focus Capital Management LLC | 54,938 5.100% |
-15,810![]() (-22.35%) |
Filing |
2023-02-14 4:03 pm Purchase |
2022-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Long Focus Capital Management LLC | 70,748 6.700% |
70,748![]() (New Position) |
Filing |